仙骨神経刺激（SNS）の市場規模、シェア、成長分析：製品別、用途別、地域別 - 産業予測 2025～2032年

仙骨神経刺激（SNS）の世界市場規模は2023年に12億米ドルと評価され、予測期間（2025～2032年）のCAGRは14.0%で、2024年の13億7,000万米ドルから2032年には39億米ドルに成長する見通しです。

世界の仙骨神経刺激（SNS）市場は、主に尿路感染症（UTI）、過活動膀胱（OAB）、便失禁などの症状を含む切迫性尿失禁の発生率の上昇によって、上昇基調にあります。SNS技術は、仙骨神経に電気インパルスを送る装置を埋め込むもので、従来の治療法では効果が得られなかった患者の膀胱や腸のコントロールを効果的に強化します。米国では約1,300万人の成人が尿失禁に悩まされており、その大半は女性であることから、安全で効果的な解決策としてのSNSの魅力は明らかです。特に英国では高齢者の間で便失禁の有病率が増加しており、この衰弱状態が生活の質や社会的相互作用に大きな影響を与えることから、市場の拡大が見込まれています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ

仙骨神経刺激（SNS）市場規模：製品別

• 市場概要
• 埋め込み型SNSデバイス
• 外付けSNSデバイス

仙骨神経刺激（SNS）市場規模：用途別

• 市場概要
• 尿失禁および便失禁
• 慢性肛門裂傷
• 切迫性尿失禁
• その他

仙骨神経刺激（SNS）市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

主要企業プロファイル

• Medtronic（USA）
• NeuroPace, Inc.（USA）
• Nevro Corp.（USA）
• Boston Scientific Corporation（USA）
• Synapse Biomedical Inc.（USA）
• Johnson & Johnson（USA）
• Biomedical Life Systems Inc.（USA）
• Kegel8（Savantini Limited）（UK）
• EnteroMedics Inc.（USA）
• LivaNova PLC（UK）
• Inspire Medical Systems Inc.（USA）
• Beijing PINS Medical Co., Ltd.（China）
• Saluda Medical Pty Ltd.（Australia）

結論と推奨事項

Global Sacral Nerve Stimulation (SNS) Market size was valued at USD 1.2 billion in 2023 and is poised to grow from USD 1.37 billion in 2024 to USD 3.9 billion by 2032, growing at a CAGR of 14.0% during the forecast period (2025-2032).

The global Sacral Nerve Stimulation (SNS) market is on an upward trajectory, primarily driven by the rising incidence of urge incontinence, including conditions like Urinary Tract Infections (UTI), Overactive Bladder (OAB), and fecal incontinence. SNS technology involves implanting a device that sends electrical impulses to the sacral nerves, effectively enhancing bladder and bowel control in patients who have not found relief through traditional therapies. With around 13 million adults in the U.S. affected by urinary incontinence, predominantly women, the appeal of SNS as a safe and effective solution is evident. The increasing prevalence of fecal incontinence, particularly among the elderly in the UK, underscores a growing market, as this debilitating condition significantly impacts quality of life and social interaction.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Sacral Nerve Stimulation (Sns) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Sacral Nerve Stimulation (SNS) Market Segmental Analysis

Global Sacral Nerve Stimulation (SNS) Market is segmented by Product, Application and region. Based on Product, the market is segmented into Implantable SNS Devices and External SNS Devices. Based on Application, the market is segmented into Urinary and Fecal Incontinence, Chronic Anal Fissure, Urge Incontinence and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Sacral Nerve Stimulation (SNS) Market

The global Sacral Nerve Stimulation (SNS) market is experiencing significant growth due to a surge in cases of urge incontinence, including conditions like Urinary Tract Infections (UTIs) and a rising incidence of Overactive Bladder (OAB) and fecal incontinence. SNS presents an effective treatment alternative for patients who have not found relief through conventional therapies or medications. The increasing prevalence of urinary and fecal disorders, especially among the elderly, propels the demand for SNS devices. This market driver is primarily motivated by the urgent need to enhance the quality of life for affected individuals, improve bladder function, and reduce the adverse effects of these issues on daily living.

Restraints in the Global Sacral Nerve Stimulation (SNS) Market

A notable restraint within the global Sacral Nerve Stimulation (SNS) market is the substantial financial burden associated with the devices and their associated procedures. The costs of procuring the SNS device, conducting the surgical implantation, and managing follow-up care and potential complications can deter both patients and healthcare providers from pursuing this treatment option. Furthermore, restrictive reimbursement policies and limitations set by healthcare payers exacerbate the issue, further restricting access to SNS therapies. This financial challenge can impede broader adoption and growth in the market, especially in regions that face healthcare resource limitations or economic constraints.

Market Trends of the Global Sacral Nerve Stimulation (SNS) Market

The Global Sacral Nerve Stimulation (SNS) market is witnessing a significant trend towards the adoption of miniaturization and wireless technology. Manufacturers are increasingly developing compact SNS devices that prioritize patient comfort and convenience, catering to the rising demand for minimally invasive treatments. This focus on smaller devices not only simplifies implantation procedures but also potentially diminishes post-operative complications. Additionally, the incorporation of wireless technology enhances patient monitoring and data collection, enabling remote programming and personalized treatment plans. As a result, this trend promises to reduce patients' reliance on frequent clinic visits, ultimately improving the overall treatment experience and outcomes in SNS therapy.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Sacral Nerve Stimulation (SNS) Market Size by Product & CAGR (2025-2032)

• Market Overview
• Implantable SNS Devices
• External SNS Devices

Global Sacral Nerve Stimulation (SNS) Market Size by Application & CAGR (2025-2032)

• Market Overview
• Urinary and Fecal Incontinence
• Chronic Anal Fissure
• Urge Incontinence
• Others

Global Sacral Nerve Stimulation (SNS) Market Size & CAGR (2025-2032)

• North America (Product, Application)
  • US
  • Canada
• Europe (Product, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroPace, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nevro Corp. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synapse Biomedical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomedical Life Systems Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kegel8 (Savantini Limited) (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EnteroMedics Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inspire Medical Systems Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beijing PINS Medical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Saluda Medical Pty Ltd. (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations